Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Clinical trial NCT00003505 · WITHDRAWN
Trial details
- NCT number
- NCT00003505
- Sponsor
- Burzynski Research Institute
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.